Mesenchymal stromal cell therapy for liver diseases

Mohammed Alfaifi, Young Woo Eom, Philip N. Newsome, Soon Koo Baik

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

The therapeutic potential of mesenchymal stromal cells (MSCs) in the treatment of liver fibrosis is predominantly based on their immunosuppressive properties, and their ability to secrete various trophic factors. This potential has been investigated in clinical and preclinical studies. Although the therapeutic mechanisms of MSC transplantation are still not fully characterised, accumulating evidence has revealed that various trophic factors secreted by MSCs play key therapeutic roles in regeneration by alleviating inflammation, apoptosis, and fibrosis as well as stimulating angiogenesis and tissue regeneration in damaged liver. In this review, we summarise the safety, efficacy, potential transplantation routes and therapeutic effects of MSCs in patients with liver fibrosis. We also discuss some of the key strategies to enhance the functionality of MSCs, which include sorting and/or priming with factors such as cytokines, as well as genetic engineering.

Original languageEnglish
Pages (from-to)1272-1285
Number of pages14
JournalJournal of Hepatology
Volume68
Issue number6
DOIs
Publication statusPublished - 2018 Jun

Fingerprint

Cell- and Tissue-Based Therapy
Mesenchymal Stromal Cells
Liver Diseases
Liver Cirrhosis
Regeneration
Genetic Engineering
Cell Transplantation
Therapeutic Uses
Therapeutics
Immunosuppressive Agents
Fibrosis
Transplantation
Apoptosis
Cytokines
Inflammation
Safety
Liver

All Science Journal Classification (ASJC) codes

  • Hepatology

Cite this

Alfaifi, Mohammed ; Eom, Young Woo ; Newsome, Philip N. ; Baik, Soon Koo. / Mesenchymal stromal cell therapy for liver diseases. In: Journal of Hepatology. 2018 ; Vol. 68, No. 6. pp. 1272-1285.
@article{b5fbe50879d6410884d315e07db5ccb0,
title = "Mesenchymal stromal cell therapy for liver diseases",
abstract = "The therapeutic potential of mesenchymal stromal cells (MSCs) in the treatment of liver fibrosis is predominantly based on their immunosuppressive properties, and their ability to secrete various trophic factors. This potential has been investigated in clinical and preclinical studies. Although the therapeutic mechanisms of MSC transplantation are still not fully characterised, accumulating evidence has revealed that various trophic factors secreted by MSCs play key therapeutic roles in regeneration by alleviating inflammation, apoptosis, and fibrosis as well as stimulating angiogenesis and tissue regeneration in damaged liver. In this review, we summarise the safety, efficacy, potential transplantation routes and therapeutic effects of MSCs in patients with liver fibrosis. We also discuss some of the key strategies to enhance the functionality of MSCs, which include sorting and/or priming with factors such as cytokines, as well as genetic engineering.",
author = "Mohammed Alfaifi and Eom, {Young Woo} and Newsome, {Philip N.} and Baik, {Soon Koo}",
year = "2018",
month = "6",
doi = "10.1016/j.jhep.2018.01.030",
language = "English",
volume = "68",
pages = "1272--1285",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier",
number = "6",

}

Mesenchymal stromal cell therapy for liver diseases. / Alfaifi, Mohammed; Eom, Young Woo; Newsome, Philip N.; Baik, Soon Koo.

In: Journal of Hepatology, Vol. 68, No. 6, 06.2018, p. 1272-1285.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Mesenchymal stromal cell therapy for liver diseases

AU - Alfaifi, Mohammed

AU - Eom, Young Woo

AU - Newsome, Philip N.

AU - Baik, Soon Koo

PY - 2018/6

Y1 - 2018/6

N2 - The therapeutic potential of mesenchymal stromal cells (MSCs) in the treatment of liver fibrosis is predominantly based on their immunosuppressive properties, and their ability to secrete various trophic factors. This potential has been investigated in clinical and preclinical studies. Although the therapeutic mechanisms of MSC transplantation are still not fully characterised, accumulating evidence has revealed that various trophic factors secreted by MSCs play key therapeutic roles in regeneration by alleviating inflammation, apoptosis, and fibrosis as well as stimulating angiogenesis and tissue regeneration in damaged liver. In this review, we summarise the safety, efficacy, potential transplantation routes and therapeutic effects of MSCs in patients with liver fibrosis. We also discuss some of the key strategies to enhance the functionality of MSCs, which include sorting and/or priming with factors such as cytokines, as well as genetic engineering.

AB - The therapeutic potential of mesenchymal stromal cells (MSCs) in the treatment of liver fibrosis is predominantly based on their immunosuppressive properties, and their ability to secrete various trophic factors. This potential has been investigated in clinical and preclinical studies. Although the therapeutic mechanisms of MSC transplantation are still not fully characterised, accumulating evidence has revealed that various trophic factors secreted by MSCs play key therapeutic roles in regeneration by alleviating inflammation, apoptosis, and fibrosis as well as stimulating angiogenesis and tissue regeneration in damaged liver. In this review, we summarise the safety, efficacy, potential transplantation routes and therapeutic effects of MSCs in patients with liver fibrosis. We also discuss some of the key strategies to enhance the functionality of MSCs, which include sorting and/or priming with factors such as cytokines, as well as genetic engineering.

UR - http://www.scopus.com/inward/record.url?scp=85044955340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044955340&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2018.01.030

DO - 10.1016/j.jhep.2018.01.030

M3 - Review article

C2 - 29425678

AN - SCOPUS:85044955340

VL - 68

SP - 1272

EP - 1285

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 6

ER -